Patents by Inventor Goran K. Hansson

Goran K. Hansson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 3-HYDROXYANTHRANILIC ACID (3-HAA) THERAPY FOR PREVENTION AND TREATMENT OF HYPERLIPIDEMIA AND ITS CARDIOVASULAR COMPLICATIONS
    Publication number: 20140296567
    Abstract: The present invention relates to the use of a tryptophan metabolite, 3-hydroxyanthranilic acid (3-HAA) or a functional analogue thereof, for prophylactic and/or therapeutic treatment of mammals, in special humans, against hyperlipidemia and its cardiovascular complications, i.e. atheroma formation, myocardial infarction and heart failure, ischemic stroke and transient ischemic attacks, renal impairment, aortic aneurysms and critical limb ischemia caused by atherosclerosis.
    Type: Application
    Filed: July 13, 2012
    Publication date: October 2, 2014
    Inventors: Goran K. Hansson, Daniel F.J. Ketelhuth
  • FUSION PROTEINS COMPRISING ANTIGENIC APOB-100 PROTEIN FRAGMENTS AND A PROTEIN CARRIER, RELATED COMPOSITIONS, METHODS AND SYSTEMS FOR TREATMENT AND/OR PREVENTION OF ATHEROSCLEROSIS
    Publication number: 20140037672
    Abstract: A fusion protein comprising an antigenic fragment of apoB-100 and a suitable carrier and related compositions methods and systems.
    Type: Application
    Filed: August 5, 2013
    Publication date: February 6, 2014
    Inventors: Jan NILSSON, Goran K. HANSSON, Jan HOLMGREN
  • Fusion proteins and related compositions, methods and systems for treatment and/or prevention of atherosclerosis
    Patent number: 8506964
    Abstract: A fusion protein comprising an antigenic fragment of apoB-100 and a suitable carrier and related compositions methods and systems.
    Type: Grant
    Filed: February 4, 2011
    Date of Patent: August 13, 2013
    Assignee: CardioVax, LLC
    Inventors: Jan Nilsson, Goran K. Hansson, Jan Holmgren
  • Immunomodulatory methods and systems for treatment and/or prevention of atherosclerosis and related proteins, peptides and compositions
    Publication number: 20130189292
    Abstract: Immunostimulatory methods and systems for treating or preventing atherosclerosis and/or a condition associated thereto in an individual and related compounds and compositions.
    Type: Application
    Filed: September 22, 2011
    Publication date: July 25, 2013
    Applicant: CARDIOVAX, LCC
    Inventor: Goran K. Hansson
  • Peptide-based immunization therapy for treatment of atherosclerosis
    Patent number: 8436139
    Abstract: The present invention relates to a fragment of apolipoprotein B, for immunization for prophylactic or therapeutic treatment of mammals, including humans, against ischemic cardiovascular diseases, in particular myocardial infarction or stroke, as well as diagnosing the presence or absence of antibodies related to increased or decreased risk of developing ischemic cardiovascular diseases including stroke, using said peptide in an assay, pharmaceutical compositions comprising the peptide. The invention further encompasses a particular peptide sequence aggravating disease, which sequence then can be used for diagnostic assays.
    Type: Grant
    Filed: March 10, 2006
    Date of Patent: May 7, 2013
    Assignee: CardioVax, LLC
    Inventor: Göran K. Hansson
  • FUSION PROTEINS AND RELATED COMPOSITIONS, METHODS AND SYSTEMS FOR TREATMENT AND/OR PREVENTION OF ATHEROSCLEROSIS
    Publication number: 20110300172
    Abstract: A fusion protein comprising an antigenic fragment of apoB-100 and a suitable carrier and related compositions methods and systems.
    Type: Application
    Filed: February 4, 2011
    Publication date: December 8, 2011
    Inventors: Jan NILSSON, Goran K. Hansson, Jan Holmgren
  • PEPTIDE-BASED IMMUNIZATION THERAPY FOR TREATMENT OF ATHEROSCLEROSIS
    Publication number: 20090092618
    Abstract: The present invention relates to a fragment of apolipoprotein B, for immunization for prophylactic or therapeutic treatment of mammals, including humans, against ischemic cardiovascular diseases, in particular myocardial infarction or stroke, as well as diagnosing the presence or absence of antibodies related to increased or decreased risk of developing ischemic cardiovascular diseases including stroke, using said peptide in an assay, pharmaceutical compositions comprising the peptide. The invention further encompasses a particular peptide sequence aggravating disease, which sequence then can be used for diagnostic assays.
    Type: Application
    Filed: October 31, 2008
    Publication date: April 9, 2009
    Applicant: CARDIOVAX
    Inventor: Goran K. Hansson